Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire


As promised , Pfizer Inc reported quarterly earnings during pre-market, but the anticipated release failed to impress after the pharmaceutical company didn't maintain expectations. Revenue missed Wall Street projections, dipping 2% from $13.15 billion to $12.9 billion.



from Biotech News